231 related articles for article (PubMed ID: 27494903)
1. Identification of novel macrolides with antibacterial, anti-inflammatory and type I and III IFN-augmenting activity in airway epithelium.
Porter JD; Watson J; Roberts LR; Gill SK; Groves H; Dhariwal J; Almond MH; Wong E; Walton RP; Jones LH; Tregoning J; Kilty I; Johnston SL; Edwards MR
J Antimicrob Chemother; 2016 Oct; 71(10):2767-81. PubMed ID: 27494903
[TBL] [Abstract][Full Text] [Related]
2. Exogenous IFN-β has antiviral and anti-inflammatory properties in primary bronchial epithelial cells from asthmatic subjects exposed to rhinovirus.
Cakebread JA; Xu Y; Grainge C; Kehagia V; Howarth PH; Holgate ST; Davies DE
J Allergy Clin Immunol; 2011 May; 127(5):1148-54.e9. PubMed ID: 21329968
[TBL] [Abstract][Full Text] [Related]
3. Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells.
Vareille M; Kieninger E; Alves MP; Kopf BS; Möller A; Geiser T; Johnston SL; Edwards MR; Regamey N
Thorax; 2012 Jun; 67(6):517-25. PubMed ID: 22213737
[TBL] [Abstract][Full Text] [Related]
4. Azithromycin induces anti-viral responses in bronchial epithelial cells.
Gielen V; Johnston SL; Edwards MR
Eur Respir J; 2010 Sep; 36(3):646-54. PubMed ID: 20150207
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication.
Marcellini A; Swieboda D; Guedán A; Farrow SN; Casolari P; Contoli M; Johnston SL; Papi A; Solari R
Eur J Pharmacol; 2021 Feb; 893():173839. PubMed ID: 33359650
[TBL] [Abstract][Full Text] [Related]
6. Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses.
Becker TM; Durrani SR; Bochkov YA; Devries MK; Rajamanickam V; Jackson DJ
Ann Allergy Asthma Immunol; 2013 Nov; 111(5):397-401. PubMed ID: 24125148
[TBL] [Abstract][Full Text] [Related]
7. N'-substituted-2'-O,3'-N-carbonimidoyl bridged macrolides: novel anti-inflammatory macrolides without antimicrobial activity.
Bosnar M; Kragol G; Koštrun S; Vujasinović I; Bošnjak B; Bencetić Mihaljević V; Marušić Ištuk Z; Kapić S; Hrvačić B; Brajša K; Tavčar B; Jelić D; Glojnarić I; Verbanac D; Culić O; Padovan J; Alihodžić S; Eraković Haber V; Spaventi R
J Med Chem; 2012 Jul; 55(13):6111-23. PubMed ID: 22697905
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D increases the antiviral activity of bronchial epithelial cells in vitro.
Telcian AG; Zdrenghea MT; Edwards MR; Laza-Stanca V; Mallia P; Johnston SL; Stanciu LA
Antiviral Res; 2017 Jan; 137():93-101. PubMed ID: 27838350
[TBL] [Abstract][Full Text] [Related]
9. Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells.
Schögler A; Kopf BS; Edwards MR; Johnston SL; Casaulta C; Kieninger E; Jung A; Moeller A; Geiser T; Regamey N; Alves MP
Eur Respir J; 2015 Feb; 45(2):428-39. PubMed ID: 25359346
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibacterial activity of modithromycin, a novel 6,11-bridged bicyclolide, against respiratory pathogens, including macrolide-resistant Gram-positive cocci.
Sato T; Tateda K; Kimura S; Iwata M; Ishii Y; Yamaguchi K
Antimicrob Agents Chemother; 2011 Apr; 55(4):1588-93. PubMed ID: 21220534
[TBL] [Abstract][Full Text] [Related]
11. Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agents.
Peric M; Browne FA; Jacobs MR; Appelbaum PC
Clin Ther; 2003 Jan; 25(1):169-77. PubMed ID: 12637118
[TBL] [Abstract][Full Text] [Related]
12. Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation.
Menzel M; Akbarshahi H; Tufvesson E; Persson C; Bjermer L; Uller L
Oncotarget; 2017 May; 8(19):31601-31611. PubMed ID: 28415826
[TBL] [Abstract][Full Text] [Related]
13. Chronic IL-33 expression predisposes to virus-induced asthma exacerbations by increasing type 2 inflammation and dampening antiviral immunity.
Werder RB; Zhang V; Lynch JP; Snape N; Upham JW; Spann K; Phipps S
J Allergy Clin Immunol; 2018 May; 141(5):1607-1619.e9. PubMed ID: 28947081
[TBL] [Abstract][Full Text] [Related]
14. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus.
Wark PA; Johnston SL; Bucchieri F; Powell R; Puddicombe S; Laza-Stanca V; Holgate ST; Davies DE
J Exp Med; 2005 Mar; 201(6):937-47. PubMed ID: 15781584
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of Achillea clavennae essential oil against respiratory tract pathogens.
Skocibusić M; Bezić N; Dunkić V; Radonić A
Fitoterapia; 2004 Dec; 75(7-8):733-6. PubMed ID: 15567252
[TBL] [Abstract][Full Text] [Related]
16. Clarithromycin decreases rhinovirus replication and cytokine production in nasal epithelial cells from subjects with bronchial asthma: effects on IL-6, IL-8 and IL-33.
Yamaya M; Nomura K; Arakawa K; Sugawara M; Deng X; Lusamba Kalonji N; Nishimura H; Yamada M; Nagatomi R; Kawase T
Arch Pharm Res; 2020 May; 43(5):526-539. PubMed ID: 28861755
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro antibiotic activity of 16-membered 9-O-arylalkyloxime macrolides.
Fu H; Marquez S; Gu X; Katz L; Myles DC
Bioorg Med Chem Lett; 2006 Mar; 16(5):1259-66. PubMed ID: 16343900
[TBL] [Abstract][Full Text] [Related]
18. Mechanical forces suppress antiviral innate immune responses from asthmatic airway epithelial cells following rhinovirus infection.
Veerati PC; Reid AT; Nichol KS; Wark PAB; Knight DA; Bartlett NW; Grainge CL
Am J Physiol Lung Cell Mol Physiol; 2023 Aug; 325(2):L206-L214. PubMed ID: 37280545
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Macrolide Antibiotics Effective against Multi-Drug Resistant Gram-Negative Pathogens.
Myers AG; Clark RB
Acc Chem Res; 2021 Apr; 54(7):1635-1645. PubMed ID: 33691070
[TBL] [Abstract][Full Text] [Related]
20. Reduced Antiviral Interferon Production in Poorly Controlled Asthma Is Associated With Neutrophilic Inflammation and High-Dose Inhaled Corticosteroids.
Simpson JL; Carroll M; Yang IA; Reynolds PN; Hodge S; James AL; Gibson PG; Upham JW
Chest; 2016 Mar; 149(3):704-13. PubMed ID: 26836898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
